Theo-24
NDC 52244-400, theophylline anhydrous, capsule, extended release, from ENDO USA, Inc..
- Product NDC
- 52244-400
- Status
- Listed
- Labeler
- ENDO USA, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA081034
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52244-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS400 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52244-400-10 | 52244040010 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52244-400-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7a108fa0-c230-475f-be93-6f864b98a410NADAC price for package 52244040010
GET /v1/drugs/nadac/52244040010
Use it
Look up 52244-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52244-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52244-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.